Professional Documents
Culture Documents
Nanoparticulate Drug Delivery System: Mr. Sagar Kishor Savale
Nanoparticulate Drug Delivery System: Mr. Sagar Kishor Savale
NANOPARTICULATE
DRUG DELIVERY SYSTEM
NANOPARTICLES
.
: Nanoparticles are particles made of natural or
synthetic polymers ranging in size from 50 to 500 nm. They consist of
macromolecular materials in which the active principle ( drug or biologically
active material ) is dissolved, entrapped, and or to which the active principle
is adsorbed or attached.
there are mainly 2 type of nanoparticles
NANOPARTICLES
MATRIX RESERVIOR
type type
NANOSPHERES NANOCAPSULES
IMPROVED EFFICACY
REDUCED TOXICITY
ENHANCED DISTRIBUTION
IMPROVED PATIENT COMPLIANCE
EXAMPLE :
IN CANCER CHEMOTHERAPY, CYTOSTATIC
DRUGS DAMAGE BOTH MALIGNANT AND
NORMAL CELLS ALIKE . BUT NANODRUG
DELIVERY SELECTIVELY TARGETS
MALIGNANT TUMOR ONLY…..
TYPES OF NANOPARTICLES :
1. POLYMERIC NANOPARTICLE
2. SOLID LIPID NANOPARTICLE
3. NANOSUSPENSION
4. POLYMERIC MICELLES
5. CERAMIC NANOPARTICLES
6. LIPOSOMES
7. DENDRIMERS
8. MAGNETIC NANOPARTICLES
9. NANOSHELLS COATED WITH GOLD
10. NANOWIRES
11. NANOPORES
12. QUANTUM DOTS
13. FERROFLUIDS
1. POLYMERIC NANOPARTICLES
Application :
• Controlled & targetted drug delivery
2. SOLID LIPID NANOPARTICLES
Colloidal Carrier System
Size : 100 – 500 nm
Delivery medium for lipophilic drugs
ADVANTAGES :
Good Biocompatibility, low toxicity & stability
3. NANOSUSPENSION
Good for poorly soluble drugs
Size : 200 – 600 nm
Drug powder + surfactant in high pressure
homogenisation → Nanoparticles
4. POLYMERIC MICELLES
• Miceller systems for systemic delivery of water-
insoluble drugs
• Amphiphilic copolymer self associate to form
micelles in water.
• Small size < 100 nm in diameter leads to avoiding of
renal excretion and RES
• Small size also leads to endothelial cell
permeability
• Accumulate greatly in tumor cells than in normal
ADVANTAGES :
Better thermodynamic stability in physiological
solution
Stable & prolonged systemic circulation time
Rapid invivo dissociation is prevented
5. CERAMIC NANOPARTICLES
SIZE : < 50 nm
Applications :
1. Catalysis
2. Thermal insulation
3. Electrode material
4. Environment filters
5. Controlled release drug carriers
12. Quantum Dots
Highly light absorbing luminescent
semiconductor nanoparticles
Size : 2-8 nm in diameter
Luminescence properties of semiconductor is
sensitive to local envrm and nanocrystal surface
prepartion.
CdSe-CdS core shell
Range : 550nm to 630 nm
InP & InAs
Range : Near infrared region
Fuctionalisation with mercaptoacetic acid or thin
silica layer makes it water soluble
Covalent attachment of proteins to mercaptoacetic
acid makes it biocompatible
Binding to cell surface, insertion in cell surface &
binding to cell nucleii is possible due to
conjugation of nanoparticle with targeting protein
13. Ferrofluids
Colloidal solutions of iron oxide magnetic
nanoparticle covered by polymer layer coated with
affinity molecules s/a Ab
Size: 25-100 nm radius
Hence they behave as a solution rather than
suspension
ADVANTAGES OF NANOSIZING OF DRUGS
Increase surface area
Enhances solubility
Increase rate of dissolution
Increase oral bioavailability
More rapid onset of therapeutic action
Decreased dose
Decreased patient-to-patient variability
Target specificity
Limited side effects
Limitations
Expensive therapy
Excess use of PVA as a detergent issues with
toxicity
Limited targeting abilities
Discontinuation of therapy is not possible
Conclusion
Polymeric systems have great potential in drug
delivery application
Still none of this systems is applied in practice to
patients- FDA approval requires extensive toxicity
investigations
Approaches for the preparation
Methods of preparation
1) Amphiphilic macromolecule cross-linking
a) Heat cross-linking.
b) Chemical cross-linking.
Desolvation (solvent
competing agent)
Protein aggregates (coacervates)
Resolvation
(alcohol)
Protein colloidal dispersion
Crosslinking
(aldehyde)
Gelatin & Tween 20 were dissolved in aq. phase & PH was adjusted to
optimum value. Solutions were heated ,then quenching at 4oC for 24h.The
leads to colloidal dispersion of aggregated gelatin. The aggregates were
finally cross linked using glutaraldehyde.The size of nanospheres were of
200 nm. The ideal PH range is 5.5-6.5.
The first includes swollen monomer micelles as the site of nucleation &
polymerization.
The monomer is emulsified in the non solvent phase with the help of
surfactant molecules.
The solvent used for polymer is poorly miscible with dispersion phase &
thus diffuses & evaporates out slowly on continual stirring
Emulsification
O/W emulsion
Solvent evaporation
nanospheres
Polymeric Solvent evaporation PEG with PEO Protein Fast drug release
coating for 4 hours
Solid lipid Hot homogenization Stearic acid in 0.1% Insulin 80% entrapment
poloxamer 188 efficiency
nanoparticles Co-precipitation Dextran coated iron Cancer treatment 74% to 95% drug
followed by separation oxide entrapment
Contd.
Nanocarrier Preparation Polymer/lipid Drug Advantage/
system method based system Application
Quantum dots Modified one pot Positively charged Gene delivery Imaging agents
method CdTe QD’s
Nanosized
Magnetic field External Magnetic field of different gradients and profiles applied to the body can
concentrate magneto-sensitive DDS in required areas.
Effective Targeting
Patient Compliance
Cost effectiveness
3) Sterilization of Nanoparticles
REF; Advances in lipid nanodispersions for parenteral drug delivery and targeting by Panayiotis P.
Constantinides, Mahesh V. Chaubal, Robert Shorr. Biopharmaceutical and Drug Delivery Consulting, LLC,
Gurnee, IL, USA; Baxter Healthcare, Round Lake, IL, USA.
3) Ocular Drug Delivery.
Biodegradable as well as water soluble polymer possessing ocular tolerability can be used to
sustain the release of the drug.
It offers quick onset of action initially and then control release of active moiety which is required
by most pulmonary disorders.
Successful targeting of peptide Dalargin to brain by employing surface modified poly (isobutyl
cyanoacrylate) Nanoparticle has been the major achievement in target drug delivery.
DNA delivery DNA gelatin nanoparticles, DNA Enhanced delivery & higher
chitosan nanoparticles, expression levels
4. Multifunctional Therapeutics
Developing nanoscale devices that integrate
diagnostic and therapeutic functions.
5. Quality of Life Enhancement in Cancer Care
Designing nanoscale devices that can optimally
deliver medications for treating side effects due to
chronic anticancer therapy, including pain, nausea,
loss of appetite, depression,difficulty in breathing
and emesis.
6. Interdisciplinary Training
Coordinating efforts to provide cross-training in
molecular and systems biology to nanotechnology
engineers and in nanotechnology to cancer
researchers.
Recent advances
An emerging, interdisciplinary science
Integrates chemistry, physics, biology, materials engineering,
earth science, and computer science.
Targetted and controlled drug delivery, Novel carrier systems; S.P Vyas and
R.K.Khar , CBS publishers and distributors, New Delhi, pg no : 331-385.
Pharmaceutical dosage form and drug delivery; Ram I. Mahato, CRC press;
pg no : 258-260.
Advances in controlled and novel drug delivery ; Jain N.K. ,CBS publishers and
distributors, New Delhi, pg no : 408-426.
www. nanoproject.org
www.nanomanufacturing.eu
2) Chen Y, Dalwadi G, Benson H. Drug delivery across the blood-brain barrier. Current
Drug Delivery 2004; vol .1, pg no.361-376.
3) Binding and release of drugs into and from thermo sensitive poly(N-vinyl
caprolactam) nanoparticles.
* Henna Vihola , Antti Laukkanen , Jouni Hirvonen , Heikki Tenhu .
Division of Pharmaceutical Technology, Viikki Drug Discovery Technology Center,
University of Helsinki, PB 56, FIN-00014, Helsinki, Finland.
Journal of pharmaceutical science.
THANK YOU
THANK YOU…!